“These medicines will give people more treatment options and help them to live well for longer,” says Pharmac’s Director Equity and Engagement, Dr Nicola Ngawati. “We expect about 180 people will ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

Through endocrine disruption, PFAS may: harm the liver and kidney harm reproductive health cause tumors and cancer increase the risk of obesity alter cholesterol levels Individuals can become ...

Doctors at a private city hospital removed a massive 3-kilogram neuroendocrine tumour (NET) from a patient’s liver. The intricate ... According to national cancer institute, US, NET forms ...